U.S. markets open in 5 hours 29 minutes

Isodiol International Inc. (ISOLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0393-0.0019 (-4.61%)
At close: 3:51PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0412
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0370 - 0.0462
52 Week Range0.0320 - 0.4240
Avg. Volume166,059
Market Cap1.826M
Beta (5Y Monthly)1.03
PE Ratio (TTM)N/A
EPS (TTM)-0.8920
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more

    Isodiol International Inc. Provides Shareholder Update

    The company achieved strong revenue growth during the year, only to have this positive momentum halted during the last several months by a few small, however significant impacts of supply and demand. Unfortunately, this increased competition had an adverse effect on the bulk ingredient pricing model, resulting in record low margins across the industry and ultimately forcing a pivot in our sales strategies and operations to focus on branded finished products.


    Isodiol International Inc. Reports Second Quarter 2020 Financial Results

    VANCOUVER, BC / ACCESSWIRE / December 3, 2019 / Isodiol International Inc. (CSE:ISOL)(OTCQB:ISOLF)(FSE:LB6B.F) (the "Company" or "Isodiol"), announces that it has filed its consolidated financial statements and MD&A for the three months ended September 30, 2019 and issues shares to settle debt. The Company has reported revenues of $1.878M for its second quarter. The Company attributes the decrease in revenue primarily to management restructuring and the continued focus on long term, higher margin growth.


    Isodiol International Inc. Announces Successful Launch of Iso-Sport Products at The Vitamin Shoppe

    VANCOUVER, BC / ACCESSWIRE / October 9, 2019 / Isodiol International Inc. (CSE:ISOL) (OTCQB:ISOLF) (FSE:LB6B.F) (the "Company" or "Isodiol"), announces it has entered into a strategic relationship with Vitamin Shoppe, Inc. (VSI) ("The Vitamin Shoppe") for the launch of the Company's Iso-Sport products. Iso-Sport will serve as a leading brand of sports performance cannabinoid (CBD) hemp extract products at The Vitamin Shoppe. The Vitamin Shoppe is an omni-channel specialty retailer of nutritional products that continues to expand its CBD hemp extract offerings to meet consumer demand and serve as a trusted retailer of quality health and wellness supplements.